The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Eosinophilia-Myalgia Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Eosinophilia-Myalgia Syndrome


High impact information on Eosinophilia-Myalgia Syndrome


Chemical compound and disease context of Eosinophilia-Myalgia Syndrome


Biological context of Eosinophilia-Myalgia Syndrome


Anatomical context of Eosinophilia-Myalgia Syndrome


Gene context of Eosinophilia-Myalgia Syndrome


Analytical, diagnostic and therapeutic context of Eosinophilia-Myalgia Syndrome


  1. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Hibbs, J.R., Mittleman, B., Hill, P., Medsger, T.A. Arthritis Rheum. (1992) [Pubmed]
  2. Pulmonary hypertension in a patient with tryptophan-induced eosinophilia-myalgia syndrome. Yakovlevitch, M., Siegel, M., Hoch, D.H., Rutlen, D.L. Am. J. Med. (1991) [Pubmed]
  3. Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination. Kita, H., Mayeno, A.N., Weyand, C.M., Goronzy, J.J., Weiler, D.A., Lundy, S.K., Abrams, J.S., Gleich, G.J. J. Allergy Clin. Immunol. (1995) [Pubmed]
  4. Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Smith, B.E., Dyck, P.J. Neurology (1990) [Pubmed]
  5. Mononeuropathy multiplex in tryptophan-associated eosinophilia-myalgia syndrome. Selwa, J.F., Feldman, E.L., Blaivas, M. Neurology (1990) [Pubmed]
  6. Tryptophan-induced eosinophilia-myalgia syndrome. Medsger, T.A. N. Engl. J. Med. (1990) [Pubmed]
  7. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Silver, R.M., McKinley, K., Smith, E.A., Quearry, B., Harati, Y., Sternberg, E.M., Heyes, M.P. Arthritis Rheum. (1992) [Pubmed]
  8. Interleukin-4 levels in the eosinophilia-myalgia syndrome. Kaufman, L.D., Gruber, B.L., Needleman, B.W. Am. J. Med. (1991) [Pubmed]
  9. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayeno, A.N., Belongia, E.A., Lin, F., Lundy, S.K., Gleich, G.J. Mayo Clin. Proc. (1992) [Pubmed]
  10. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. Johnson, K.L., Klarskov, K., Benson, L.M., Williamson, B.L., Gleich, G.J., Naylor, S. J. Rheumatol. (1999) [Pubmed]
  11. Aspects of melatonin manufacturing and requirements for a reliable active component. Laforce, R., Rigozzi, K., Paganetti, M., Mossi, W., Guainazzi, P., Calderari, G. Biological signals and receptors. (1999) [Pubmed]
  12. The eosinophilia-myalgia syndrome: the Los Alamos Conference. Hertzman, P.A., Falk, H., Kilbourne, E.M., Page, S., Shulman, L.E. J. Rheumatol. (1991) [Pubmed]
  13. Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome. Sidransky, H., Verney, E., Cosgrove, J.W., Latham, P.S., Mayeno, A.N. Toxicol. Appl. Pharmacol. (1994) [Pubmed]
  14. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. Belongia, E.A., Hedberg, C.W., Gleich, G.J., White, K.E., Mayeno, A.N., Loegering, D.A., Dunnette, S.L., Pirie, P.L., MacDonald, K.L., Osterholm, M.T. N. Engl. J. Med. (1990) [Pubmed]
  15. Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Kaufman, L.D., Gruber, B.L., Gregersen, P.K. Lancet (1991) [Pubmed]
  16. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Owen, W.F., Petersen, J., Sheff, D.M., Folkerth, R.D., Anderson, R.J., Corson, J.M., Sheffer, A.L., Austen, K.F. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  17. Safety of L-tryptophan for pigs. Chung, T.K., Gelberg, H.B., Dorner, J.L., Baker, D.H. J. Anim. Sci. (1991) [Pubmed]
  18. Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan. Illa, I., Dinsmore, S., Dalakas, M.C. Hum. Pathol. (1993) [Pubmed]
  19. Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan. Mizutani, T., Mizutani, H., Hashimoto, K., Nakamura, Y., Kishida, M., Taniguchi, H., Murata, M., Kuzuhara, S., Shimizu, M. J. Am. Acad. Dermatol. (1991) [Pubmed]
  20. Effect of 3-phenylamino-L-alanine on tryptophan binding to rat hepatic nuclear envelopes. Sidransky, H., Verney, E., Cosgrove, J.W., Latham, P.S. Toxicology (1994) [Pubmed]
  21. Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome. Yamaguchi, Y., Tsunoda, J., Suda, T., Miura, Y., Shioiri-Nakano, K., Kasahara, T. Biochem. Biophys. Res. Commun. (1991) [Pubmed]
  22. Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Berger, P.B., Duffy, J., Reeder, G.S., Karon, B.L., Edwards, W.D. Mayo Clin. Proc. (1994) [Pubmed]
  23. Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities. Kaufman, L.D., Varga, J., Gomez-Reino, J.J., Jimenez, S., Targoff, I.N. Clin. Immunol. Immunopathol. (1995) [Pubmed]
  24. PMS and eosinophilia-myalgia syndrome. Guinan, M.E. Journal of the American Medical Women's Association (1972) (1990) [Pubmed]
  25. Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome. Mayeno, A.N., Lin, F., Foote, C.S., Loegering, D.A., Ames, M.M., Hedberg, C.W., Gleich, G.J. Science (1990) [Pubmed]
  26. Characterization of contaminants in EMS-associated L-tryptophan samples by high-performance liquid chromatography. Toyo'oka, T., Yamazaki, T., Tanimoto, T., Sato, K., Sato, M., Toyoda, M., Ishibashi, M., Yoshihira, K., Uchiyama, M. Chem. Pharm. Bull. (1991) [Pubmed]
WikiGenes - Universities